Study Shows ALS Patients May Benefit From More Glucose
A study co-authored by Barrow researchers Dr. Rita Sattler and Dr. Robert Bowser found that people with amyotrophic lateral sclerosis (ALS) may benefit from more glucose. It is widely known that people with the neurodegenerative…
Dr. Jeremy Shefner Announces Results of FORTITUDE-ALS Trial
Dr. Jeremy Shefner, chair of the Department of Neurology at Barrow, recently presented the results of the FORTITUDE-ALS trial at the annual meeting of the American Academy of Neurology in Philadelphia. The Phase 2 trial…
Barrow, CloudMedx to Use AI to Better Understand ALS Progression
The Gregory W. Fulton ALS and Neuromuscular Disease Center at Barrow is collaborating with a healthcare artificial intelligence (AI) company to track disease progression in people with amyotrophic lateral sclerosis (ALS). Currently, little is known…
Barrow Neurologist Discusses Football and ALS
Dr. Shafeeq Ladha, director of the Gregory W. Fulton ALS and Neuromuscular Disease Center at Barrow, weighed in on the discussion of amyotrophic lateral sclerosis (ALS) in football players. Retired football player Tim Green suspects…
